CannaMD

SEPTEMBER 10, 2020

Data from the National Institute of Health indicates that younger women are more likely to use marijuana during pregnancy, with urine toxicology testing showing that 19% of pregnant women aged 18-25 screened positive for marijuana use. These numbers reflect both non-medical and medicinal marijuana use.

Marijuana 59

Marijuana Therapy Data THC 59

Cannabis Law Report

AUGUST 23, 2021

He added that significant data is still needed to inform policy regarding use of consumer cannabis products. She acknowledged that “FDA is considering the possibility of new legal pathways for CBD products.”.

Pets 105

Pets Hemp CBD Food 105

Cannabis Law Report

SEPTEMBER 20, 2019

DEA increases the cannabis research quota. Data indicates cannabis-containing vaping products losing market share to other cannabis products after recently reported health concerns. Headset data reflects that the share of vaping sales have declined materially in the wake of the recently publicized vaping health concerns.

Vaping 40

Vaping Banking Research and Development DEA 40

Canna Law Blog

NOVEMBER 6, 2021

The following year, President Richard Nixon declared drug abuse public enemy number one, and in 1973, he formed the Drug Enforcement Administration (DEA). The DEA limits how much psilocybin can be produced annually, which drives up costs, and the agency imposes other unnecessary burdens on researchers.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Connor & Connor PLLC

AUGUST 15, 2024

Currently, marijuana is a Schedule I substance, meaning it is thought to have no medical value, a high probability of addiction, and a lack of any accepted safety or use in medically supervised treatment. If Congress would like to change the legal status of marijuana, they would do so before or after the DEA makes a final scheduling decision.

Marijuana 52

Marijuana DEA Policy Business 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Later that year, Doblin sued the DEA for the first time. Lyle Craker, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

NORML

FEBRUARY 18, 2020

Because cannabis is still illegal under federal law, the DEA and other federal law enforcement would be able to use federal funds to shut down medical marijuana programs. The data speaks for itself. No patient should have to worry about losing access to cannabis treatment options. Thanks for being in the fight with us, NORML.

Marijuana 346

Marijuana DEA Programs Patients 346

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

As policies become more data-driven and progressive, cultivation and production technologies have continued to improve drastically over the past several years. The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse.

Recreational 52

Recreational Data Cannabis DEA 52

SpeedWeed

DECEMBER 28, 2018

Which Cannabis Strains Are Highest in CBD, According to Lab Data? Bringing pharmaceutical CBD to market will make it available to patients in every state (with a doctor’s prescription), allow it to be covered by health insurance, and guarantee a product that’s produced to high standards. RELATED STORY.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Cannabis Law Report

JULY 30, 2019

Cannabis is not a “gateway” drug, according to the ASA and the DEA’s own statements cited in the August 2016 U.S. “Today, Americans for Safe Access (ASA), the leading advocacy organization dedicated to ensuring safe and legal access to cannabis (marijuana) for therapeutic use and research, and Aurelius Data , Inc.(AD),

Marijuana 45

Marijuana Patients Research and Development Programs 45